Advanced or Metastatic Cholangiocarcinoma

NCT05653817 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Cholangiocarcinoma

Interventions

DRUG: Carrilizumab
DRUG: Albumin-bound paclitaxel
DRUG: Apatinib

Sponsor

First Affiliated Hospital Xi'an Jiaotong University